Effects of Prenatal Exposure to Carbamazepine on Brainstem Auditory Evoked Potentials in Infants of Epileptic Mothers

Abstract

The purpose of this study was to determine if there are any correlations between carbamazepine serum levels of epileptic mothers during pregnancy and the brainstem auditory evoked potentials in their infants as an index of drug neurotoxicity in newborns exposed prenatally. We included 20 epileptic mothers with carbamazepine medication and their 20 otherwise healthy infants. The study was conducted from September 1, 1993, to December 15, 1999. Serum carbamazepine determinations were performed monthly by enzymatic immunoanalysis in the mothers, and the averages for each trimester during pregnancy were calculated. Brainstem auditory evoked potentials were performed at 10.2 ± 4.6 weeks of postnatal life. Pearson's correlations were calculated between carbamazepine serum levels during pregnancy and waves and interwave intervals of brainstem auditory evoked potentials. Both examinations were performed without knowledge of the results of the other investigations. No alterations in the infants' brainstem auditory evoked potentials were evident, and carbamazepine determinations were within therapeutic levels. Significant Pearson's correlations between latencies of waves III and V and third trimester of carbamazepine serum concentration levels and I-V interwave intervals to third-trimester minimum serum levels of carbamazepine were found. The findings suggest that the higher carbamazepine levels in mothers are related to increased latencies in waves III and V and I-V interwave intervals in infants subclinically, which could be an early index of fetal neurotoxicity. (J Child Neurol 2002;17:364-368).

References

Ferrendelli JA , Mathews GC : Neuropharmacology of antiepileptic medications: Mechanisms of action, in Wyllie E (ed): The Treatment of Epilepsy. Principles and Practice . Philadelphia, Lea and Febiger , 1993 , 735-742.

Meadow R. : Anticonvulsants in pregnancy. Arch Dis Child 1991;66: 62-65.

Helge H. : Physical, mental, and social development, including diseases: Review of the literature, in Janz D (ed): Epilepsy, Pregnancy and the Child. New York, Raven Press, 1982, 391-395.

Velasco M. , Velasco F. , Almanza X. , Coats AC : Subcortical correlates of the auditory brain stem potentials in man: Bipolar EEG and multiple unit activity and electrical stimulation. Electroencephalogr Clin Neurophysiol 1982;53:133-142.

Rothenberg SJ , Poblano A. , Garza MS : Prenatal and perinatal low level lead exposure alters brainstem auditory evoked responses in infants . Neurotoxicology 1994;15:695-699.

Salamy A. , Eldredge L. , Anderson J. , Bull D. : Brain-stem transmission time in infants exposed to cocaine in utero . JPediatr 1990;117: 627-629.

Green JB , Walcoff M. , Lucke JF : Phenytoin prolongs far-field somatosensory and auditory evoked potential interpeak latencies. Neurology 1982;32:85-88.

van der Meyden CH , Bartel PR , Sommers DK , et al: Effect of acute doses of controlled-release carbamazepine on clinical, psychomotor, electrophysiological, and cognitive parameters of brain function. Epilepsia 1992 ;33:335-342.

Japaridze G. , Kvernadze D. , Geladze T. , Kevanishvili Z. : Effects of carbamazepine on auditory brainstem response, middle latency response, and slow cortical potential in epileptic patients. Epilepsia 1993;34:1105-1109.

10.

Yuksel A. , Senocak D. , Souzer D. , et al: Effects of carbamazepine and valproate on brainstem auditory evoked potentials. Childs Nerv Syst 1995;11:474-477.

11.

Verroti A. , Trotta D. , Cutarella R. , et al: Effects of antiepileptic drugs on evoked potentials in epileptic children. Pediatr Neurol 2000;23:397-402.

12.

Groce JB , Casto DT , Gal P. : Carbamazepine and carbamazepine-epoxide serum protein binding in newborn infants . Ther Drug Monit 1985;7:274-276.

13.

Nuwer MR , Aminoff M. , Goodin D. , et al: IFCN recommended standards from brain-stem auditory evoked potentials. Report of IFCN Committee. Electroencephalogr Clin Neurophysiol 1994;91: 112-117.

14.

Dawson-Saunders B. , Trapp RG : Medical Biostatistics [in Spanish] . México City, Manual Moderno, 1997 .

15.

Poblano A. , Garza MS , Ibarra PJ : Clinical utility of the brain stem auditory evoked potentials in newborns [in Spanish]. Bol Med Hosp Infant Mex 1995 ;52:262-270.

16.

Paulson GW , Paulson RB : Teratogenic effects of anticonvulsants. Arch Neurol 1981;38:140-143.

17.

Garza MS , Ibarra PJ , Poblano A. , et al: Epilepsy and pregnancy. Prospective study of 100 cases [in Spanish] . Ginecol Obstet Mex 1996;64:449-454.

18.

Gaily E. , Kantola-Sorsa E. , Granström ML : Intelligence of children of epileptic mothers. J Pediatr 1988;113:677-684.

19.

Jones KL , Lacro RV , Johnson KA , Adams J. : Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989;320:1661-1666.

20.

Huttenlocher PR Dendritic and synaptic development in human cerebral cortex: Time course and critical periods. Dev Neuropsychol 1999;16:347-349.

21.

Sininger YS , Doyle KJ , Moore JK : Auditory system development, experimental auditory deprivation, and development of speech perception and hearing. Pediatr Clin North Am 1999;46:1-14.

22.

Rotteveel JJ , de Graaf, Colon EJ , et al: The maturation of the central auditory conduction in preterm infants until three months post term. II. The auditory brainstem responses (ABRs). Hear Res 1987;26:21-35.

23.

Birnholz JC , Banacerraf BR : The development of human fetal hearing. Science 1983;222:222-228.

24.

Moore JK , Perazzo LM , Braun A. : Time course of axonal myelination in the human brainstem auditory pathway . Hear Res 1995;87:21-31.

25.

Despland PA : Maturational changes in the auditory system as reflected in human brainstem evoked responses. Dev Neurosci 1985;7:73-80.

26.

van der Pol MC , Hadders-Algra M. , Huisjes HJ , Touwen Bcl : Antiepileptic medication in pregnancy: Late effects on the children's central nervous system development. Am J Obstet Gynecol 1991;164:121-128.